Benign neoplasm: Scapula and long bones of upper limb

CD2_BENIGN_BONE_SCAPULA_LONG_UPPER

tongue neoplasm: A neoplasm (disease) that involves the tongue.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D16.0& Hospital discharge: ICD-9 — 2134 Hospital discharge: ICD-8 — 21303 Cause of death: ICD-10 — D16.0& Cause of death: ICD-9 — 2134 Cause of death: ICD-8 — 21303 2 out of 7 registries used, show all original rules.	387
4. Check minimum number of events None	387
5. Include endpoints None	387
6. Filter based on genotype QC (FinnGen only)	376

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D16
Name in latin: Neoplasma benignum scapulae sive ossium longorum membri superioris

NAME	CD2_BENIGN_BONE_SCAPULA_LONG_UPPER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D160
HD_ICD_9	2134
HD_ICD_8	21303
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D160
COD_ICD_9	2134
COD_ICD_8	21303
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Scapula and long bones of upper limb based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3001	1340	1651
Only index persons	2788	1256	1532
Unadjusted period prevalence (%)
Whole population	0.04	0.04	0.05
Only index persons	0.05	0.05	0.06
Median age at first event (years)
Whole population	28.48	34.17	23.81
Only index persons	27.91	34.14	22.80

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	376	198	178
Unadjusted period prevalence (%)	0.08	0.07	0.08
Median age at first event (years)	34.86	35.27	34.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
387: Matched controls
3870

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D16.0

ICD-10 Finland

Benign neoplasm: Scapula and long bones of upper limb

+∞

307.7

269

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

43.2

106.2

21303

ICD-8 Finland

Benign neoplasm of bone and cartilage, Ossium longorum extremitatis superioris et scapulae

+∞

93.6

NBR20

NOMESCO Finland

Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm

195.1

50.2

2134A

ICD-9 Finland

Benign neoplasm of bone and articular cartilage, Scapula and long bones of upper limb

+∞

34.9

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

10.1

30.5

D16.1

ICD-10 Finland

Benign neoplasm: Short bones of upper limb

144.7

26.0

9102

FHL

Trepanation or removal of the local bone process

31.2

22.2

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.2

17.6

131

D16.2

ICD-10 Finland

Benign neoplasm: Long bones of lower limb

23.2

17.1

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

14.1

14.4

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

78.0

13.7

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

44.7

11.0

NGR20

NOMESCO Finland

Intralesional or marginal excision of tumor of knee or lower leg

61.7

10.7

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

5.6

10.5

NB6AA

NOMESCO Finland

Humerus X-ray examination

9.5

10.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.1

8.9

108

606

GA1CG

NOMESCO Finland

Extensive MRI of chest

81.6

7.4

NCR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of elbow or forearm

81.6

7.4

9101

FHL

Bone biopsy

+∞

7.3

N02AX02

ATC

tramadol; systemic, rectal

1.8

7.3

167

1146

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

5.8

7.2

NB1AD

NOMESCO Finland

Shoulder CT examination

7.2

7.1

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

6.9

NB4AA

NOMESCO Finland

Scapula X-ray examination

23.0

6.7

NBR30

NOMESCO Finland

Extensive or radical excision of soft tissue tumour of shoulder or upper arm

+∞

6.3

L08

ICPC

Shoulder symptom/complaint

1.9

6.1

496

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

161

1235

1.52

3.87

2.1

2.0

—

(3021788) Differential panel - Synovial fluid

3.59

3.64

1.8

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

4.09

3.62

1.6

1.3

70.71

50.42

—

(3037522) Nuclear Ab [Titer] in Serum

418

1.70

3.52

1.6

1.3

350.77

530.00

titre

0.76

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

159

1237

1.48

3.48

5.2

6.0

1.21

1.22

mmol/l

0.40

141

1132

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

100

707

1.56

3.42

2.0

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

158

1236

1.47

3.33

2.4

2.2

75.33

74.47

nmol/l

0.15

152

1125

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

170

1351

1.46

3.29

6.1

6.7

1.21

mmol/l

0.63

139

1157

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

708

1.54

3.20

3.1

3.2

832.64

828.60

ng/l

0.01

591

(3013512) EKG study

110

809

1.50

3.11

3.4

3.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

263

2294

1.46

2.97

4.6

3.8

9.51

10.20

mm/h

0.49

241

2126

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.75

2.87

3.3

7.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

8.42

2.75

4.4

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.49

2.74

1.4

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.77

2.74

1.0

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

523

1.54

2.70

1.3

9.95

28.02

iu/ml

4.38

184

(3026493) Urate [Moles/volume] in Serum or Plasma

101

755

1.46

2.59

2.5

2.6

1630.38

6881.90

umol/l

1.58

669

(3012516) Albumin [Mass/volume] in Urine

103

774

1.45

2.57

3.0

3.3

19.77

220.96

mg/l

1.10

523

(3005719) IgG [Mass/volume] in Serum or Plasma

241

1.74

2.56

1.5

2.3

9.61

10.29

g/l

0.61

223

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.43

2.48

1.6

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

2.95

2.43

1.0

1.1

1.42

4.26

u/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.40

2.42

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

107

820

1.42

2.39

3.4

4.0

3.00

9.79

mg/mmol

3.61

539

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

2.55

2.38

3.2

4.0

57.15

58.23

0.12

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

523

1.49

2.31

1.4

1.3

1.15

8.52

u/ml

3.25

204

(3013826) Glucose [Moles/volume] in Serum or Plasma

201

1722

1.35

2.23

4.1

4.6

6.41

6.62

mmol/l

0.78

189

1593

(3014133) Dog dander IgE Ab [Units/volume] in Serum

2.73

2.22

1.0

1.1

15.74

1.74

u/ml

—

(3018418) pH of Serum or Plasma

106

825

1.39

2.15

4.1

3.9

7.40

0.11

147

(3044640) Blood type and Crossmatch panel - Blood

118

936

1.38

2.13

2.1

2.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

2.50

2.12

1.1

0.91

2.21

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

2.31

2.10

1.1

0.31

2.15

u/ml

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

208

1.70

2.09

3.5

3.9

1.21

1.22

mmol/l

0.53

184

(3020650) Glucose [Presence] in Urine

5.05

2.07

1.8

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

2.37

2.07

1.1

8.24

7.58

u/ml

—

(1616796) Gas panel - Central venous blood

2.37

2.07

4.7

3.0

—

(3000494) Fungus identified in Specimen by Culture

367

1.51

1.98

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

2.40

1.97

2.7

3.5

3.55

4.67

e9/l

1.20

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.77

1.94

1.1

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

2.77

1.94

3.3

1.8

84.50

91.05

—

(3044941) Cell count panel - Synovial fluid

2.77

1.94

1.7

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.79

1.94

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.79

1.94

1.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

235

2092

1.31

1.86

4.5

3.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

339

3196

1.49

1.83

14.8

13.6

3.95

3.97

mmol/l

0.48

320

3106

(3026008) Bacteria identified in Urine by Culture

101

801

1.35

1.80

3.1

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

338

3188

1.48

1.78

14.7

13.5

139.75

139.69

mmol/l

0.17

321

3105

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

2.53

1.75

1.1

1.3

0.49

0.47

nmol/l

—

(3042631) Mycobacterium sp identified in Specimen

2.53

1.75

3.2

2.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.95

1.73

1.1

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

565

1.38

1.67

1.4

1.7

393.74

10183734.00

pmol/l

0.50

491

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.19

1.66

1.0

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.19

1.66

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.19

1.66

1.0

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

142

1195

1.30

1.66

3.8

4.7

36.53

36.37

g/l

0.13

134

1123

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.53

1.60

1.1

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

258

2350

1.29

1.59

7.1

7.3

74.59

76.29

u/l

0.36

250

2215

(3008401) Mugwort IgE Ab [Units/volume] in Serum

2.24

1.58

1.1

1.51

4.88

u/ml

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

688

1.34

1.57

2.0

1.9

2.93

2.98

mg/l

0.06

605

(3039443) Prostate specific Ag panel - Serum or Plasma

1.96

1.56

1.2

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

179

1562

1.27

1.55

4.6

6.2

10.44

11.23

umol/l

0.69

168

1478

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.89

1.51

1.7

1.2

—

(3023419) Bacteria identified in Sputum by Culture

2.47

1.49

1.8

2.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

171

1492

1.26

1.46

6.3

6.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

110

1.76

1.45

2.1

1.5

1.10

1.19

g/l

0.56

105

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.15

1.44

1.0

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

2.34

1.44

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

256

1.49

1.42

4.5

3.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.97

1.40

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

2.11

1.40

1.9

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.22

1.38

1.1

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

174

1530

1.25

1.37

3.6

3.3

0.00

estimate

-0.00

276

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.97

1.36

1.0

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

106

879

1.28

1.36

2.9

3.1

8.30

8.23

mmol/l

0.04

761

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

1.35

0.0

17.9

—

1513.37

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

1.35

0.0

12.0

—

823.11

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.07

1.34

1.8

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

146

1261

1.25

1.34

15.0

11.3

1.22

1.18

inr

0.18

391

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

303

1.43

1.32

1.6

1.8

—

(3022145) Colonoscopy Study observation

338

1.41

1.31

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1.82

1.29

1.5

1.3

—

2.52

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.80

1.29

1.0

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

171

1509

1.24

1.28

4.7

4.4

0.00

estimate

-0.00

293

(3035350) Ketones [Presence] in Urine by Test strip

171

1510

1.24

1.27

3.7

3.2

0.00

estimate

0.50

303

(21494815) CD4 cells/100 lymphocytes in Specimen

2.42

1.25

2.2

1.9

33.97

36.35

—

(3019225) pH of Specimen

256

1.45

1.23

4.1

4.4

—

(3045424) Erythrocytes [Presence] in Urine

2.07

1.23

1.6

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.65

1.22

2.4

2.9

34380.00

40742.37

ug/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

274

1.43

1.21

3.9

3.1

—

(3002256) Pathology report gross observation

379

1.37

1.20

1.4

1.2

—

(3001604) Monocytes [#/volume] in Blood

176

1567

1.23

1.19

6.0

5.6

0.59

0.57

e9/l

0.58

160

1372

(3003458) Phosphate [Moles/volume] in Serum or Plasma

345

1.38

1.18

4.6

6.2

1.00

1.03

mmol/l

0.49

320

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

127

1096

1.24

1.15

4.0

3.4

36.13

37.01

ng/l

0.03

686

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

339

1.37

1.13

9.5

6.2

—

(3015736) pH of Urine

140

1224

1.23

1.12

3.2

3.0

5.50

5.74

—

124

(3045142) Bone marrow Pathology biopsy report

2.28

1.11

1.0

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

297

1.39

1.10

1.6

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

161

1.52

1.09

5.0

9.1

92.76

94.00

0.22

161

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.40

1.09

1.0

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.21

1.08

1.1

1.3

—

(3006315) Basophils [#/volume] in Blood

175

1569

1.21

1.08

6.0

5.6

0.04

e9/l

0.95

157

1378

(3015377) Calcium [Moles/volume] in Serum or Plasma

112

960

1.23

1.07

2.3

3.3

2.35

2.36

mmol/l

0.56

103

863

(3019060) Gas panel - Arterial blood

162

1.51

1.07

3.0

7.4

—

(4062490) Immunoglobulin typing, IgG

2.14

1.06

1.0

1.5

—

(40768443) Skin Pathology biopsy report

122

1.59

1.04

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

106

1.63

1.04

1.9

2.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.29

1.03

1.6

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.79

1.01

1.0

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

247

2298

1.21

1.00

3.2

3.0

44.24

43.40

u/l

0.08

233

2186

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

161

1443

1.20

0.97

2.6

2.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.96

0.97

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.87

0.97

1.8

3.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.87

0.97

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

314

2999

1.25

0.94

12.2

11.2

86.99

86.67

ml/min/173m2

0.09

256

2455

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

478

1.28

0.92

2.5

2.6

1.27

0.88

e6/l

0.17

278

(3029937) Albumin [Presence] in Urine by Test strip

804

1.22

0.92

4.4

3.6

0.00

0.01

estimate

0.69

285

(3002179) Metamyelocytes/100 leukocytes in Blood

220

1.39

0.90

3.8

4.4

0.67

0.54

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.81

0.88

2.3

1.9

5.98

5.31

mmol/24h

—

(3028026) IgM [Mass/volume] in Serum or Plasma

196

1.41

0.87

1.6

1.5

3.15

1.15

g/l

0.65

184

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

332

3199

1.27

0.86

14.1

12.3

24.80

21.74

mg/l

0.67

261

2495

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.65

0.85

3.2

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

253

2377

1.19

0.85

4.2

3.9

14.38

14.56

pmol/l

0.59

232

2188

(3019198) Lymphocytes [#/volume] in Blood

178

1625

1.18

0.85

6.0

5.6

1.82

1.98

e9/l

1.04

163

1456

(3035637) Corticotropin [Mass/volume] in Plasma

1.89

0.82

1.8

1.4

—

(40768797) Stomach Pathology biopsy report

404

1.27

0.81

1.2

1.3

—

(40758558) Short blood count panel - Blood

786

1.21

0.81

5.7

7.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

124

1102

1.18

0.81

2.1

1.8

101.14

94.51

pmol/l

0.60

589

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

451

1.26

0.79

2.5

2.8

2.41

2.19

e6/l

0.06

249

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

117

1037

1.18

0.78

3.3

3.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

280

1.32

0.77

4.7

9.2

5.43

5.18

kpa

0.54

268

(3027801) Oxygen [Partial pressure] in Arterial blood

280

1.32

0.77

4.7

9.2

12.63

12.36

kpa

0.10

269

(3004616) Nuclear Ab [Presence] in Serum

1.78

0.76

2.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.71

0.76

1.1

1.6

—

(3023368) Bacteria identified in Blood by Culture

744

1.20

0.75

4.7

4.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

228

1.34

0.75

4.0

4.5

0.40

0.16

—

(3016502) Oxygen saturation in Arterial blood

255

1.32

0.75

4.6

9.8

93.99

95.87

0.51

245

(3016018) Differential panel - Cerebral spinal fluid

2.10

0.75

1.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.01

0.73

1.0

1.5

13.94

10.59

umol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.81

0.73

1.0

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

205

0.67

0.72

1.3

1.7

—

(3008898) HLA-B27 [Presence]

143

1.42

0.71

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.93

0.71

1.8

2.7

—

(3013115) Eosinophils [#/volume] in Blood

176

1623

1.15

0.71

6.2

6.0

0.19

e9/l

0.07

159

1444

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

197

1.34

0.68

1.3

—

40.50

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

695

1.19

0.67

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

194

1807

1.15

0.67

7.2

9.3

4.16

4.00

e9/l

0.44

172

1596

(3020891) Body temperature

103

1.47

0.66

4.3

4.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1.59

0.66

1.5

1.2

—

40.21

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

300

2885

1.18

0.65

4.9

4.5

9.98

2.25

mu/l

0.46

274

2682

(3007164) IgA [Mass/volume] in Serum or Plasma

698

1.18

0.65

1.4

1.3

2.14

2.40

g/l

0.96

446

(3035941) MCH [Entitic mass]

367

3602

1.37

0.64

19.7

17.9

30.05

30.25

1.50

358

3558

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

298

2866

1.17

0.64

5.1

39.00

39.40

mmol/mol

0.31

276

2704

(3024731) MCV [Entitic volume]

367

3603

1.36

0.63

19.7

18.0

90.19

90.56

0.91

358

3560

(3026361) Erythrocytes [#/volume] in Blood

367

3603

1.36

0.63

19.8

18.0

4.59

4.57

e12/l

0.28

351

3520

(3050129) First trimester maternal screen panel - Serum or Plasma

130

1.40

0.62

1.2

1.4

—

(40761511) CBC panel - Blood by Automated count

347

3385

1.24

0.62

12.9

11.3

—

(3010813) Leukocytes [#/volume] in Blood

367

3605

1.35

0.60

19.7

18.0

6.57

6.66

e9/l

0.46

349

3522

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.60

0.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

627

1.18

0.60

1.5

1.4

22.10

21.64

nmol/l

0.09

541

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.59

0.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.59

0.0

7.1

—

38.75

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

367

3606

1.34

0.59

20.0

18.1

137.61

137.65

g/l

0.02

359

3562

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

440

1.21

0.59

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

123

1.40

0.59

2.6

2.1

—

(3017181) Myelocytes/100 leukocytes in Blood

248

1.27

0.57

4.0

4.3

1.00

0.93

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

221

1.29

0.57

2.5

2.3

—

13.66

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.68

0.57

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.63

0.56

1.0

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

518

1.19

0.55

3.4

3.6

2133.60

405.24

ng/l

0.44

369

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

126

0.63

0.55

3.5

2.4

0.59

0.66

—

126

(3022096) Basophils/100 leukocytes in Blood

154

1428

1.13

0.54

6.0

5.7

0.64

0.67

0.25

144

1343

(3045414) Leukocytes [Presence] in Urine

125

1.38

0.54

1.8

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

351

1.22

0.54

3.7

4.1

31.41

31.02

0.07

245

(3003740) Influenza virus B Ag [Presence] in Specimen

1.46

0.53

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1.46

0.53

1.3

1.5

1.00

0.89

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.46

0.53

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

152

1.33

0.53

1.8

3.1

0.03

0.12

e6/l

2.14

145

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

0.62

0.52

3.7

10.2

2.22

1.58

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

0.62

0.52

3.7

10.3

0.72

0.95

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.51

0.52

1.0

1.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.51

0.52

1.2

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

243

1.25

0.51

4.8

10.0

127.30

122.50

g/l

0.71

235

(3009542) Hematocrit [Volume Fraction] of Blood

366

3602

1.30

0.51

19.5

18.0

41.24

40.86

0.82

343

3426

(3044889) 12 lead EKG panel

224

2133

1.12

0.49

4.0

3.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

108

0.64

0.49

1.6

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.57

0.49

2.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

245

1.24

0.48

1.8

2.5

81.31

69.03

ml/min/173m2

0.92

108

(36304419) Bacteria [Presence] in Urine

793

1.14

0.48

2.9

2.8

—

(3019069) Monocytes/100 leukocytes in Blood

159

1487

1.12

0.48

6.4

5.9

8.74

8.45

0.62

150

1405

(3037756) Immunofixation for Serum or Plasma

1.50

0.48

1.7

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.50

0.48

3.0

3.1

—

(3018095) Leukocytes [#/volume] in Urine

114

1046

1.13

0.47

3.3

3.6

26.48

98.70

e6/l

1.43

742

(3006504) Eosinophils/100 leukocytes in Blood

158

1478

1.12

0.47

6.1

5.6

3.02

2.82

0.49

150

1392

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

498

1.17

0.47

2.4

3.0

2.42

2.44

mmol/l

1.08

432

(3028707) Methadone [Presence] in Urine by Screen method

0.61

0.46

1.0

1.6

—

(40768793) Breast Pathology biopsy report

0.60

0.46

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

201

1.26

0.46

2.1

2.6

71.75

73.37

e9/l

0.08

151

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

311

3025

1.14

0.46

4.4

4.0

5.97

5.86

mmol/l

0.79

285

2802

(3019309) Folate [Moles/volume] in Red Blood Cells

490

1.17

0.46

1.8

1.6

1163.50

nmol/l

0.00

377

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

112

1.35

0.45

1.2

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

885

1.13

0.44

2.9

3.1

30.02

130.33

e6/l

0.77

690

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

166

1.28

0.44

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

240

0.78

0.44

3.5

5.92

5.79

kpa

0.15

233

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.57

0.42

3.0

3.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.52

0.41

1.2

—

(3028433) Virus identified in Specimen by Culture

0.00

0.41

0.0

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.41

0.0

1.5

—

65.72

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.41

0.0

6.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.41

0.0

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

861

1.12

0.41

3.4

2.8

—

(3007461) Platelets [#/volume] in Blood

365

3600

1.24

0.41

19.9

18.0

259.11

251.65

e9/l

1.51

350

3522

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.40

0.0

1.8

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

30.11

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

76.24

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.34

0.40

1.1

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.48

0.40

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.40

0.0

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.39

0.0

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

507

1.15

0.39

2.2

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.37

0.38

3.0

2.9

—

1.21

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

115

0.69

0.37

2.6

3.6

9.25

2259.49

u/ml

—

101

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.31

0.37

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

461

1.15

0.37

2.1

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

226

1.21

0.37

7.2

8.2

7.93

9.03

mmol/l

0.44

218

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.27

0.36

1.1

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.47

0.36

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

135

1.27

0.36

2.7

2.4

8849.86

4258.42

u/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

123

0.73

0.35

1.2

1.4

—

(3036489) Thrombin time

117

1.29

0.35

2.3

1.8

20.67

21.83

0.50

106

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

265

0.82

0.35

1.2

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.40

0.35

1.0

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.35

0.34

2.1

2.2

—

(3030467) Casts [#/volume] in Urine by Automated count

804

1.11

0.33

2.9

0.35

0.36

e6/l

0.03

617

(3021589) Normoblasts [#/volume] in Blood

149

1414

1.09

0.32

10.3

8.7

0.00

e9/l

0.55

123

1161

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

208

0.81

0.32

2.4

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

689

1.11

0.32

3.8

3.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

346

3408

1.14

0.31

9.9

9.5

28.80

27.65

u/l

0.47

334

3309

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.33

0.31

1.0

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

129

1.25

0.30

6.1

13.5

—

(3048689) Calprotectin [Mass/mass] in Stool

411

1.14

0.30

1.9

2.2

71.70

127.25

ug/g

1.66

332

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.30

0.30

2.3

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

111

1.27

0.30

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

111

1.27

0.30

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

111

1.27

0.30

1.2

1.4

—

(3000991) Gas panel - Venous blood

213

1.19

0.30

5.8

8.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

161

1539

1.08

0.29

6.2

5.7

27.91

28.58

0.38

154

1458

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.30

0.28

1.3

1.5

—

(3000330) Specific gravity of Urine by Test strip

128

0.78

0.27

3.8

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

150

1.21

0.27

1.6

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

203

0.83

0.26

3.1

2.6

4.89

4.60

kpa

0.20

196

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1.31

0.26

2.1

2.4

11.56

135.59

ug/min

—

(3003694) ABO and Rh group [Type] in Blood

928

0.92

0.26

1.6

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

160

1.20

0.26

2.4

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

159

1525

1.07

0.26

5.9

5.5

56.79

56.61

0.07

151

1444

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

572

1.10

0.25

3.2

2.8

0.77

0.72

ug/l

0.18

345

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.19

0.25

1.1

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.74

0.24

1.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

106

1.23

0.23

1.4

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

266

1.14

0.23

1.3

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.32

0.23

1.2

122.58

173.49

pmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

162

1.18

0.23

1.2

2.0

3.04

2.98

mg/l

0.02

124

(3008152) Bicarbonate [Moles/volume] in Arterial blood

162

1.18

0.23

4.5

10.1

25.35

24.83

mmol/l

0.28

152

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

702

1.08

0.23

1.9

1.7

0.74

1.19

mg/l

2.20

531

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.77

0.22

1.1

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

605

1.09

0.22

2.4

2.5

2.98

4.90

e6/l

1.44

546

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.22

0.22

1.2

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

145

1394

1.06

0.21

2.8

2.7

118.51

103.39

ug/l

0.52

130

1311

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.19

0.21

1.2

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.19

0.21

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.19

0.21

1.2

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3045716) Anion gap in Serum or Plasma

0.00

0.21

0.0

1.5

—

8.91

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.80

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.16

0.21

1.2

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.16

0.21

1.2

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1.16

0.21

2.6

5.3

423.40

357.89

umol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.21

0.0

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

187

0.85

0.20

1.0

1.3

—

(3011288) Drugs identified in Urine by Screen method

108

1.21

0.20

1.2

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.20

0.0

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.20

0.0

3.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.20

0.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.20

0.0

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

124

1190

1.06

0.19

4.1

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

165

1.16

0.19

1.1

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

373

0.90

0.19

1.6

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.13

0.19

1.0

1.1

—

(40761535) Cells panel - Urine sediment

223

1.13

0.18

4.8

3.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

119

1.18

0.18

1.3

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

769

1.07

0.18

1.3

1.74

1.41

u/ml

0.16

211

(36660697) Celiac disease serology panel - Serum

272

1.11

0.17

1.4

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

237

2322

1.05

0.17

3.3

3.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

711

1.07

0.17

1.8

1.9

—

(3027008) Opiates [Presence] in Urine

167

1.14

0.17

1.1

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.72

0.17

4.8

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.20

0.16

1.0

1.2

—

(3022621) pH of Urine by Test strip

193

0.88

0.16

2.2

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

111

1.18

0.16

1.2

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

754

1.06

0.15

4.0

18.24

21.30

1.28

321

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

823

1.06

0.15

1.7

1.49

1.42

mmol/l

0.32

707

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.10

0.15

2.0

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

311

3145

0.94

0.15

4.3

4.1

1.41

1.45

mmol/l

0.83

291

2950

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.09

0.14

2.0

1.8

0.26

0.80

g/l

—

(3000492) Spirometry study

353

1.08

0.14

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

933

1.05

0.14

2.4

57.23

60.09

u/l

0.20

872

(3025941) Bacteria identified in Stool by Culture

179

1.12

0.14

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

317

3203

0.94

0.14

4.6

4.5

2.84

2.83

mmol/l

0.05

294

3001

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.81

0.14

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.81

0.14

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.18

0.13

1.5

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

109

0.82

0.13

1.7

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

148

0.87

0.12

1.0

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

123

1.14

0.12

1.0

1.5

341.86

234.48

miu/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

385

1.07

0.12

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.11

2.2

1.7

6.51

7.34

g/l

1.27

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.11

2.2

1.7

3.47

3.64

g/l

0.25

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.11

2.2

1.7

—

(3019150) Specific gravity of Urine by Refractometry

668

0.95

0.11

4.3

3.5

1.02

kg/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.14

0.10

2.0

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

135

0.89

0.10

1.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

194

1.09

0.09

1.2

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

302

3045

0.96

0.09

3.9

3.7

1.32

1.30

mmol/l

0.22

283

2847

(3027944) Amphetamines [Presence] in Urine

165

1.10

0.09

1.1

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.07

0.08

1.0

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.07

0.08

1.0

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

113

0.88

0.08

1.5

1.9

1.53

1.44

g/l

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.79

0.08

3.0

5.9

—

177.25

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.10

0.08

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

244

1.07

0.08

1.0

1.3

73.98

147.42

iu/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.84

0.07

1.0

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.05

0.07

1.0

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

112

0.89

0.07

1.7

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.02

0.07

2.0

1.7

2.83

2.97

g/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.13

0.07

2.3

1.7

11.01

10.12

g/l

—

(21494755) Public health laboratory ask at order entry panel

433

1.04

0.07

1.2

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.11

0.06

2.6

1.9

1.66

1.47

ug/l

0.05

(3028300) Cannabinoids [Presence] in Urine

168

1.07

0.06

1.1

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

131

0.91

0.05

1.1

1.5

—

(3005033) Fetal Nuchal fold Thickness US

1.11

0.05

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

100

1.10

0.05

1.8

2.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

535

0.97

0.05

1.7

1.5

—

(1002224) Polysomnography panel

171

0.93

0.05

1.1

—

(3026782) Osmolality of Urine

575

1.03

0.05

2.8

2.6

577.42

555.32

mosm/kgh2o

0.29

496

(3014576) Chloride [Moles/volume] in Serum or Plasma

332

0.96

0.04

5.4

6.7

102.72

104.04

mmol/l

0.95

332

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

261

0.95

0.04

2.6

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

190

1.06

0.04

1.4

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

428

1.03

0.04

1.6

—

(3022313) Gas panel - Capillary blood

129

0.93

0.03

3.3

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

389

0.97

0.02

1.4

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

429

0.98

0.02

1.7

1.4

—

(1761868) Lipid panel - Serum or Plasma

129

1299

0.99

0.01

2.4

2.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.07

0.01

1.4

—

(3016879) Cocaine [Presence] in Urine

154

1.04

0.00

1.1

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

366

0.98

0.00

1.9

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

576

0.99

0.00

1.5

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

102

0.98

0.00

1.9

1.5

—

(3042936) Bacteria identified in Isolate by Culture

421

1.00

0.00

3.1

2.0

—

(4034850) Laboratory test

107

1.03

0.00

24.4

9.7

—

(4200892) Spirometry reversibility

227

1.01

0.00

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.05

0.00

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

105

1.05

0.00

2.5

1.4

—

(4035726) Immunohistochemistry procedure

255

0.98

0.00

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

194

0.98

0.00

1.3

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

79.08

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.89

0.00

1.0

1.2

—

6.33

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.1

—

13.39

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

26.36

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3024471) HLA-A [Type]

0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.98

0.00

1.1

1.3

488.13

440.07

mg/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.6

—

(3014051) Protein [Presence] in Urine by Test strip

0.88

-0.00

2.3

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

180

1.00

-0.00

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033799) Differential panel - Peritoneal fluid

0.00

-0.00

0.0

1.6

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

-0.00

0.0

2.7

—

9123.17

—

(3000285) Sodium [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.88

-0.00

1.0

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

67.44

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

-0.00

2.1

1.7

39.55

38.99

g/l

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

-0.00

0.0

6.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.90

-0.00

1.3

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

316

3160

1.00

-0.00

4.4

4.2

4.68

4.71

mmol/l

0.25

293

2977

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.96

-0.00

1.1

1.2

3.41

3.72

mmol/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.00

-0.00

1.3

1.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

5.1

—

45.39

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

1.9

—

1.19

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

2.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

52.40

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.6

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

1.0

—

3.34

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.95

-0.00

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

0.00

-0.00

0.0

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.8

—

1.20

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.00

-0.00

1.2

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.91

-0.00

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

0.89

-0.00

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

1.95

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

1.08

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.1

—

(3024932) HLA-DR beta [Type]

0.00

-0.00

0.0

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BONE_SCAPULA_LONG_UPPER and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BONE_SCAPULA_LONG_UPPER	1.04 [0.75, 1.44]	0.814
Birth year	0.993 [0.98, 1.0]	0.1

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 841 females with CD2_BENIGN_BONE_SCAPULA_LONG_UPPER died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BONE_SCAPULA_LONG_UPPER	0.846 [0.65, 1.1]	0.217
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 986 males with CD2_BENIGN_BONE_SCAPULA_LONG_UPPER died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_SCAPULA_LONG_UPPER.

N-year risk	Females	Males
1	0.075%	0.198%
5	0.646%	1.007%
10	1.443%	2.695%
15	2.829%	5.179%
20	5.114%	8.344%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BONE_SCAPULA_LONG_UPPER – Benign neoplasm: Scapula and long bones of upper limb

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Scapula and long bones of upper limb

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints